Mechanistically, bioinformatics analysis showed that miR-101 binds the EZH2 3′UTR and directly reduces EZH2 expression, indicating that miR-101 overexpression could be used in anti-fibrosis clinical application. Here, EZH2 is linked to fibrosis.